Med College of Virginia

Richmond, Virginia 232980711

0 studies enrolling now · 15 studies all time

What they study most

Bacterial Infections, Gastrointestinal Diseases, HIV Infections, HIV Seronegativity, Herpes Simplex, Lymphatic Disease, Pneumonia, Pneumocystis Carinii, Pregnancy

Studies at this site

• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children — Completed
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs — Completed
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV — Completed
• A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses — Completed
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children — Completed
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment — Completed
• A Study to Compare Two Different Anti-HIV Drug Regimens — Completed
• A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women. — Completed
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies — Completed
• Long-Term Effects of HIV Exposure and Infection in Children — Completed
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants — Completed
• A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications — Completed
• The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III) — Completed
• A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients — Completed
• Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease — Completed